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 Summary  
 
Downstream of tyrosine kinases (Dok) proteins, Dok-1 and Dok-2 are involved in the T cell 
homeostasis maintenance. Dok proteins tyrosine plays a key role in establishing negative 
feedback loops of T cell signaling. These structurally related adapter molecules contain a 
pleckstrin homology (PH) domain, generally acting as a lipid/protein-interacting module. We 
show that the presence of this PH domain is necessary for the tyrosine phosphorylation of 
Dok proteins and their negative functions in T cells.  We find that Dok-1/Dok-2 PH domains 
bind in vitro to the rare phosphoinositides species, phosphatidylinositol-5-phosphate 
(PtdIns5P). Dok tyrosine phosphorylation correlates with a PtdIns5P production in T cells 
upon TCR triggering. Further, we demonstrate that PtdIns5P increase regulates Dok tyrosine 
phosphorylation in vivo. Together, our data identify a novel lipid mediator in T cell signaling 
and suggest that PH-PtdIns5P interactions regulate T cell responses.  
  
 
 
 
 
 
 
 
 
 
Introduction 
Stimulation of membrane receptors such as the TCR on T cells induces the activation of 
protein tyrosine kinases (PTKs), and subsequently the phosphorylation of substrates, which 
contribute to the formation of intracytoplasmic multiprotein network.  The downstream of 
tyrosine kinases (Dok) proteins, Dok-1 and Dok-2 are involved in negative T cell activation 
control (1). During T cell activation, Dok proteins are tyrosine phosphorylated (2, 3). Dok-1 
and Dok-2 overexpression in T cell lines decreases IL-2 production in activated cells (4, 5) 
and loss or reduction of Dok-1 and Dok-2 expression in primary T cells enhances TCR-
mediated functions and signaling (3, 6). Moreover, mice lacking both Dok-1 and Dok-2 
develop T cell-dependent antibody responses and a spontaneous autoimmunity disease (6).  
Interestingly, Dok-1 and Dok-2 contain N-terminal pleckstrin homology (PH) domain that has 
been poorly studied. PH domains are one of the largest and most intensively investigated 
families of lipid binding domains, the majority bind weakly to phosphoinositides (PIs) with 
little or no selectivity (7). PIs are constituents of cell membranes playing a critical role in cell 
signaling pathways. Their metabolism is tightly regulated by several lipid 
kinases/phosphatases and its disruption gives rise to several pathologies (8). These PIs species 
mediate signals through their binding to proteins containing specific interaction domains 
including PH, PX, FYVE or ENTH domains (9). 
We now report that in T cell lines or primary T cells, the PH domain of Dok proteins is 
necessary for their phosphorylation and functions. Interestingly, we show that the 
phosphatidylinositol-5-phosphate (PtdIns5P) is the most relevant ligand for Dok-1 and Dok-2 
PH domains. 
PtdIns5P is a rare PIs species and is starting to emerge as a potential second messenger (10, 
11). Bacterial infection by Shigella flexneri via the virulence factor, IpgD, generates PtdIns5P 
in the host cells and induces Akt activation (12, 13). Recent evidences report that enhanced 
tyrosine phosphorylation increases cellular PtdIns5P levels (14, 15). Altogether, these data 
argue for an important role of PtdIns5P in cell signaling.  Here, we show that PtdIns5P is 
generated upon TCR triggering and regulates the tyrosine phosphorylation of negative adaptor 
proteins of T cell activation such as Dok-1 and Dok-2.   
 
 
Materials and methods 
 
Culture cells and transfection 
Jurkat JA16 and Hut-78 T cells were grown in RPMI 1640 medium, Hela cells were cultured 
in DMEM. Both medium were supplemented with 10 % heat-inactivated FCS, 2 mM L-
glutamine, and 1 mM sodium-pyruvate. PBMC from healthy donors (Etablissement Français 
du Sang, Marseille, France) were isolated on Ficoll-Hypaque (Pharmacia) gradients before 
purification of the CD4+ T cell subset using the CD4+ T cell isolation kit (Miltenyi Biotec). 
Jurkat cells were electroporated at 960 μF and 250 V using a Bio-Rad Gene Pulser or 
nucleofected according to the manufacturer’s instructions (http://www.amaxa.com/). PBMC 
were transfected using Amaxa Nucleofector technology. Hela cells were transfected using 
Lipofectamin 2000 ™ (Invitrogen).  
 
Plasmid constructs 
The HA-Dok1 and HA-Dok2 constructs were described previously (4). All the constructs 
encoding the mutants lacking the PH domain: HA-ΔPHDok1, HA-ΔPHDok2, ΔPHDok1-GFP 
and ΔPHDok2-GFP, GFP-Dok1 and GFP-Dok2, chimeric PH domain constructs: PHDok1-
GFP, PHDok2-GFP, GST-PHDok1 and GST-PHDok2, and finally several other vectors 
described previously are detailed in supplemental method. 
 
 
 
 
 
 
PtdIns binding assays 
Protein lipid-blot assays were carried out as described (16). “PIP array” and “PIP strip” were 
purchased from Echelon biosciences Inc. To reveal binding, GST mAb was used in 
immunoblotting. 
 
Surface plasmon resonance (SPR) experiments 
Detailed protocols for SPR experiments were described previously (17). Briefly, the binding 
of 1 µM protein to lipid layers containing 90% DOPC (1,2-dioleoyl-sn-glycero-3-
phosphocholine (SIGMA) and 10% PtdIns, PtdIns3P, PtdIns4P or PtdIns5P (Echelon 
biosciences Inc.) was measured. Protein binding for the 4 lanes were measured at the same 
time and all proteins were tested on the same fresh lipid layers (at least 6000 RU was 
coupled). Proteins were removed from the layers by addition of 20µl 25 µM NaOH at a flow 
rate of 100 µl/min. 
 
Phospholipid extraction and analysis 
Hut-78 (107) were stimulated with CD3 antibody (clone 289) (18) during indicated time. 
PtdIns5P was quantified by mass assay as previously described (12). The PtdIns(4,5)P2 
generated after lipid kinase assay  was extracted and analyzed by HPLC for quantification. 
 
Luciferase assay 
Luciferase assay was performed as previously described (4). 
 
T cell proliferation assay 
Primary human T cells were transfected with the Amaxa Nucleofector technology, 16 hrs 
after transfection (transfection efficiency: 40 % GFP+ cells), mixed CD4+ T cell population 
(105) was plated on 96-wells plate and left non stimulated or stimulated with OKT3 + CD28.2 
(0.5µg/ml each), or 1ng/ml PMA + 1µg/ml Ionomycin. Cells were cultured for 4 days and 
plates were pulsed with 1 µCi [3H]-thymidine/well for the last day of culturing.  
 
 
Results and discussion 
 
The loss of the PH domain blocks Dok-1 and Dok-2 tyrosine phosphorylation and their 
inhibitory properties 
Tyrosine phosphorylation of Dok proteins is also detectable in Jurkat T cells upon an optimal 
T cell activation via TCR plus CD28 co-stimulation (Fig. 1A). To investigate the role of the 
PH domain, we first compared Jurkat cells overexpressing GFP-tagged Dok-1 or Dok-2 
proteins full length or deleted for their PH domain. Dok-1 and Dok-2 proteins full length were 
tyrosine phosphorylated in stimulated cells (Fig. 1B). Interestingly, Dok proteins tyrosine 
phosphorylation was undetectable when PH domain was deleted. Therefore, PH domain is 
important for Dok-1 and Dok-2 phosphorylation. 
Overexpression of Dok-1 or Dok-2 inhibits IL-2 promoter activity in TCR plus CD28-
activated Jurkat cells (4). We used this assay to address the importance of the PH domain for 
the function of Dok proteins. Cells were transfected with HA-tagged Dok-1 and Dok-2 full 
length or deleted of their PH domain and stimulation was carried out with CD3 and CD28 
antibodies for 16 hrs. Luciferase assays revealed that IL-2 promoter activity was inhibited by 
Dok-1 or Dok-2 overexpression proteins full length (wild type, WT) (Fig. 1C). However, 
expression of PH-deleted Dok-1 or Dok-2 proteins (ΔPH) resulted in a loss of inhibitory 
effects on IL-2 promoter activity.  To confirm the importance of the PH domain in the 
regulatory function of Dok proteins, constructs encoding GFP-tagged Dok-1 or Dok-2 full 
length (WT) or deleted for their PH domain (ΔPH) were transfected in human primary T cells. 
The cells were then stimulated by CD3 and CD28 mAbs and proliferation assays were 
performed (Fig. 1D).  We observed an inhibition of T cell proliferation upon overexpression 
of Dok-1 or Dok-2, but not upon expression of their PH-deleted versions. 
Taken together, these results indicate that the PH domain is necessary for Dok 
phosphorylation and to trigger the inhibitory effects of Dok-1 and Dok-2 in activated T cells. 
We then decided to characterize the ligand of these PH domains. 
 
 
Dok-1 and Dok-2 PH domains bind PtdIns5P  
PH domains are commonly described phospholipid binding domains (7). Although little is 
known about Dok-1 and Dok-2 PH domain binding-specificity, it was reported that the PH 
domain of Dok-1 recognizes polyphosphoinositides incorporated in multilamellar vesicles 
(19). To establish whether both Dok-1 and Dok-2 PH domains have a phospholipid-binding 
activity, we tested 15 lipids including phosphoinositides in a protein lipid-blot assay using 
“PIP-Strip” membranes. 
After incubation with recombinant GST-PH Dok-1 or GST-PH Dok-2, a signal was clearly 
detectable with phosphatidylinositol monophosphate species PtdIns3P, PtdIns4P and PtdIns5P 
(Fig. 2A). By SPR analysis, GST Dok-1 and Dok-2 PH domains interacted mostly with 
PtdIns4P and PtdIns5P but not with PtdIns3P (Fig. 2B). To quantify the relative affinity of PH 
Dok-1 and Dok-2 domain for phosphoinositides, we probed a lipid blot with serial dilutions of 
eight different phosphoinositides with GST-PH Dok-1 or GST-PH Dok-2 proteins (“PIP 
array” membranes) (Fig. 2C). GST immunoblot analysis revealed that Dok-1 and Dok-2 PH 
domain bound most tightly to PtdIns5P. Although there is a low binding to other 
phosphoinositides species, PtdIns5P appears clearly as the preferential ligand for Dok-1 or 
Dok-2 PH domain.   
Dok-1 PH domain has been previously described as a potential PtdIns(3,4,5)P3 binding 
module (19), however the binding activity to phosphatidylinositol monophosphates was not 
addressed in this study. Here we observe a slight binding to PtdIns(3,4,5)P3 (Fig. 2C), but the 
binding of the PH domains of Dok proteins are stronger to PtdIns5P .Moreover, the PH 
domain of Dok proteins has not been identified as a PtdIns(3,4,5)P3 binding module in a 
recent published large scale screening for PtdIns(3,4,5)P3 partners (20). We are showing by 
independent in vitro assays that Dok-1 and Dok-2 PH domain recognize phosphatidylinositol 
monophosphates and preferentially PtdIns5P. PtdIns5P increase has been described in few 
reports and this lipid appears as a second messenger involved in cell signaling (11). Our 
results raise the possibility of a yet unknown Dok-1 and Dok-2 regulation via PtdIns5P 
binding, moreover they suggest that PtdIns5P could have an impact on T cell activation. 
Consequently, we decided to measure PtdIns5P levels under T cell activation.  
 
TCR triggering induces a PtdIns5P production in T cells 
The difficulty to detect PtdIns5P explains why it has only been quite recently biochemically 
characterized (10). Few studies report on an increase in PtdIns5P levels (21-23), and  
classically this lipid is present in low amounts in resting cells. As the method to measure 
PtdIns5P necessitates a large amount of cellular material, we used a T cell line Hut-78, instead 
of primary T cells. Hut-78 T cell line is not mutated in phosphoinositide biosynthetic 
enzymes, such as phosphatase and tensin homologue deleted in chromosome 10 (PTEN) or 
SH2 domain-containing inositol polyphosphate 5’-phosphatase (SHIP) (3). PtdIns5P levels 
were measured in T cells upon TCR triggering (Fig. 2D). Compared to unstimulated cells, a 
four time increase in PtdIns5P levels was detected after 2 min of TCR/CD3 stimulation. 
PtdIns5P amount then rapidly dropped to basal levels after 10 min. These data show for the 
first time, that PtdIns5P is detectable in T cells upon TCR triggering and suggest that it might 
be involved in early T cell signaling. In parallel, we investigated the status of Dok-2 tyrosine 
phosphorylation (Fig. 2D; upper panel). Dok-2 phosphorylation followed the same kinetic as 
PtdIns5P increase, suggesting a possible link between Dok-2 tyrosine phosphorylation and 
PtdIns5P production. 
 
PtdIns5P increase induces Dok-1 and Dok-2 proteins tyrosine phosphorylation  
To further establish a link between PtdIns5P production and Dok-1 and Dok-2 regulation, we 
used the bacterial inositol-4-phosphatase, IpgD (12). IpgD is a virulence factor of Shigella 
flexneri transforming PtdIns(4,5)P2 into PtdIns5P via its 4-phosphatase activity. IpgD ectopic 
expression induces high PtdIns5P production in Jurkat T cells (23). To study the impact of 
IpgD and thereby of PtdIns5P increase on Dok-1 and Dok-2 tyrosine phosphorylation, Jurkat 
T cells were transfected with a Myc-tagged IpgD phosphatase (WT) expression construct or 
its phosphatase-dead C438S mutant (CS) construct.  Interestingly, IpgD expression but not its 
phosphatase-dead version leads to Dok-1 and Dok-2 tyrosine phosphorylation (Fig. 3A). 
These data further indicate that PtdIns5P increase induces Dok-1 and Dok-2 phosphorylation, 
and strongly suggest that Dok-1 and Dok-2 proteins are PTK substrates downstream of 
PtdIns5P production.  To demonstrate a more direct effect of PtdIns5P on Dok-1 and Dok-2 
phosphorylation, we tested whether the overexpression of Dok-1 PH domain could inhibit 
Dok phosphorylation (competitive effect). Jurkat T cells containing detectable levels of 
tyrosine phosphorylated Dok-1 protein (overexpressing IpgD together with HA-tagged Dok-
1), were transfected with plasmids encoding the GFP-PH domain of Dok-1 (PH Dok-1 GFP). 
The  Dok-1 PH domain expression blocks Dok-1 tyrosine phosphorylation induced by IpgD 
(Fig. 3B). Similar results were reproduced in Hela cells (Fig. 3C) and extended to another 
PtdIns5P-binding module, the GFP-trimer of PHD (Plant Homeo Domain) motif of ING2 (3X 
PHD ING2 GFP) (16). Both PtdIns5P partners (PH-Dok-1 or PHD-ING2) were able to block 
Dok-1 tyrosine phosphorylation induced by PtdIns5P increase.  
To test for the specific contribution of PtdIns5P increase during ectopic IpgD expression on 
Dok-1 and Dok-2 phosphorylation, Hela cells expressing HA-tagged Dok-1 were co-
transfected with IpgD plus GFP-tagged Inp54 or the type II PtdIns5P 4-kinaseβ (PIP4KIIβ) 
(Fig. 3D). Inp54 is an inositol-5-phosphatase known to transform PtdIns(4,5)P2 into PtdIns4P 
and PIP4KIIβ is a kinase that transforms PtdIns5P into PtdIns(4,5)P2  (12). Inp54 ectopic 
expression increasing PtdIns4P was unable to induce the tyrosine phosphorylation of Dok-1 
(Fig. 3D, HA-Dok-1 plus INP54 GFP conditions). Using an in vitro SPR binding approach 
both PtdIns4P and PtdIns5P are recognized by Dok PH domains (Fig. 2B), however only 
PtdIns5P, but not PtdIns4P, is a regulator module for Dok-1 protein (Fig. 3D). When HA-
Dok-1 plus IpgD were co-expressed in presence of PIP4KIIβ, Dok-1 phosphorylation was 
lost. In control, co-expression of HA Dok-1 and PIP4KIIβ without IpgD did not lead to Dok-1 
phosphorylation. Taken together, our results indicate that PtdIns5P production controls Dok 
proteins tyrosine phosphorylation in cells.  
PtdIns5P could be a new unexpected lipid second messenger in T cell activation. It has been 
reported that the PtdIns5P production induces Akt activation in epithelial cells infected by 
Shigella flexneri probably via a PTK activation leading to the stimulation of phosphoinositide 
3’-kinase (PI3K) (13). As Dok-1 and Dok-2 PH domains are able to bind PtdIns5P and 
PtdIns5P production induces PTK activation, the PtdIns5P could bring together activated 
PTKs and their substrates (Dok proteins). PtdIns5P production could support positive cell 
signals via PI3K signaling and negative cell signals via Dok proteins.  PtdIns5P might thereby 
function as a sensor in setting the threshold for T cell activation and in maintaining T cell 
homeostasis. To investigate this hypothesis, further studies are required to better understand 
the molecular mechanisms inducing PtdIns5P increase in eukaryotic cells. 
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Figure legends 
 
Figure 1.  The PH domain of Dok1 and Dok2 proteins are required for their tyrosine 
phosphorylation and for T cell signaling down-regulation.  
(A) Jurkat T cells were left unstimulated (NS) or were stimulated with CD3 and CD28 
mAbs for 5 min. Immunoprecipitation (IP) with anti-Dok-1 mAbs then anti-
phosphotyrosine (PY) or anti-Dok-1 (Dok-1) Western Blot was performed. Similar results 
were obtained from three independent experiments. 
(B) Jurkat cells expressing GFP-tagged Dok-1 (Dok-1 GFP) or GFP-tagged Dok-1 
missing the PH domain (ΔPHDok-1 GFP) (left panel), or the corresponding Dok-2 
constructs (right panel). Cells were stimulated (+) or not (-) with CD3 plus CD28 
antibodies for 5 min. Dok-1 and Dok-2 tyrosine phosphorylation was observed after anti-
GFP IP. Similar results were obtained from two independent experiments. 
(C) Jurkat T cells were transfected with a luciferase reporter construct for IL-2 promoter 
activity plus an empty vector (mock) or vectors for the expression HA-Dok-1 (left 
diagram) or HA-Dok-2 (right diagram) wild-type (WT) or deleted for the PH domain 
(ΔPH). Two hours after transfection, the cells were stimulated with CD3 and CD28 mAbs 
for 16 hours and luciferase activity was measured. Data shown are the average of three 
independent experiments ± s.d.  
(D) Human primary T cells were transfected  with an empty vector (pEGFP-N1) or 
vectors for the expression of GFP-tagged Dok-1 (left diagram) or Dok-2 (right diagram) 
wild-type (WT), or missing the PH domain  (ΔPH). Twenty-four hours after transfection, 
cells were stimulated (+) or not (-) with CD3 and CD28 mAbs. Data shown are the 
average of three independent experiments ± s.d.  
 Figure 2. The PH domains of Dok-1 and Dok-2 bind PtdIns5P and transient increase in 
PtdIns5P cellular levels correlate with Dok-2 phosphorylation.  
(A) Dok-1/Dok-2 PH domains bind phosphatidylinositol monophosphates. The PH domain of 
Dok-1 (upper panel) and Dok-2 (lower panel) fused to GST were purified and incubated at 
0,5µg/ml with PIP strips. PA, phosphatidic acid; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PS, phosphatidylserine. LPA, Lysophosphatidic acid; LPC, 
Lysophosphocholine; S1P, sphingosine-1-Phosphate. 
(B) The PH domain of Dok-1 and Dok-2 bind to PtdIns5P and PtdIns4P containing liposomes 
in SPR. Sensorgrams showing the binding of 1 µM GST-PH Dok-1 (upper part) and GST-PH 
Dok-2 (lower part) to reconstituted indicated liposomes. PtdIns binding values were 
substracted to PtdInsP binding data. 
(C) GST-PH Dok-1 and GST-PH Dok-2 bind preferentially to PtIns5P. The GST-PH fusion 
proteins were incubated with “PIP arrays” containing serial dilutions of the indicated PI 
derivatives (100, 50, 25, 12.5, 6.3, 3.2 and 1.6 picomoles).  
(D) In vivo PtdIns5P level increases concomitant to Dok-2 phosphorylation under TCR 
triggering. Hut-78 T cells were stimulated or not (NS) with CD3 mAb for the indicated 
periods of time. PtdIns5P amounts were measured by mass assay and the relative increase in 
PtdIns5P levels were plotted in the histogram. Data are expressed as means ± SEM, * p<0.05 
(student test t-test, n=3). Cell lysates from Hut-78 cells were examined in parallel for Dok-2 
and Dok-2 phosphorylation (PY351) by Western Blot.  
 
 Figure 3.  PtdIns5P production and availability control Dok-1 and Dok-2 
phosphorylation. 
(A) Dok-1 and Dok-2 tyrosine phosphorylation increases upon the expression of IpgD WT. 
Jurkat T cells expressing HA-Dok1 or Dok2 GFP alone (NT), or co-tranfected respectively 
with pRK5-Myc IpgD or pRK5-Myc IpgD C438S for the expression of IpgD wild-type (WT) 
or its inactive form (CS) were analysed 12 hours after transfection. Note the increase in Dok-1 
and Dok-2 tyrosine phosphorylation in the presence of active IpgD.  
PtdIns5P sequestration prevents Dok-1 tyrosine phosphorylation. Jurkat T cells (B) and Hela 
cells (C) overexpressing different combinations of proteins as indicated on top were analysed 
in Western Blot. Note that Dok-1 increased phosphorylation upon IpgD gain of function is 
abolished by the overexpression of its isolated PH domain or of a triplet of the PHD domain 
of ING2.  
(D) Dok-1 phosphorylation relies on PtdIns5P but not PtdIns4P or PtdIns4,5P2  production.  
Hela cells overexpressing different combinations of enzymes (INP54 stimulates PtdIns4P 
production and PI5P4KIIβ transforms PtdIns5P in PtdIns4,5P2)  as indicated on top were 
analysed in Western Blot. INP54 was overexpressed as GFP fusion and controlled by Western 
Blot of cell lysates with anti-GFP antibodies. 
 
 
 



